DrugPatentWatch Database Preview
XERESE Drug Profile
Which patents cover Xerese, and when can generic versions of Xerese launch?
Xerese is a drug marketed by Bausch and is included in one NDA. There is one patent protecting this drug.
This drug has twenty-five patent family members in twenty-one countries.
The generic ingredient in XERESE is acyclovir; hydrocortisone. There are fifty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acyclovir; hydrocortisone profile page.
Summary for XERESE
| International Patents: | 25 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for XERESE |
| DailyMed Link: | XERESE at DailyMed |
Generic Entry Opportunity Date for XERESE
Generic Entry Date for XERESE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
CREAM;TOPICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for XERESE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| TKL Research, Inc. | Phase 3 |
| Meda Pharmaceuticals | Phase 3 |
Pharmacology for XERESE
US Patents and Regulatory Information for XERESE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | XERESE | acyclovir; hydrocortisone | CREAM;TOPICAL | 022436-001 | Jul 31, 2009 | RX | Yes | Yes | See Pricing | See Pricing | Y | See Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for XERESE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch | XERESE | acyclovir; hydrocortisone | CREAM;TOPICAL | 022436-001 | Jul 31, 2009 | See Pricing | See Pricing |
| Bausch | XERESE | acyclovir; hydrocortisone | CREAM;TOPICAL | 022436-001 | Jul 31, 2009 | See Pricing | See Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for XERESE
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Taiwan | 589191 | See Pricing |
| Australia | 1436400 | See Pricing |
| Hong Kong | 1042440 | See Pricing |
| Malaysia | 122397 | See Pricing |
| South Africa | 200103335 | See Pricing |
| Germany | 69923584 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
